[DOI] [PubMed] [Google Scholar] 395.Richards P., Parker H.E., Adriaenssens A.E., Hodgson J.M., Cork S.C., Trapp S
Actual cost-share varies by plan tier and pharmacy
This is particularly noteworthy because two competing oral small-molecule GLP-1 programs from Pfizer, lotiglipron (discontinued in 2023) and danuglipron (discontinued in April 2025), were terminated due to liver toxicity concerns
The promising preclinical data necessitates a strategic and rigorous approach to further research and development
This makes keto generally easier to sustain socially and nutritionally long-term
That distinction becomes especially important in the retatrutide era because physiology may now change faster than behavior can realistically keep pace, and honestly, I think that changes everything